ExeVir Bio
PrivateLast Round
Grant
Jun 28, 2023
Total Funding Raised
$81.78M
Company Overview
ExeVir is a biopharmaceutical company specializing in single-domain antibody-based therapies aimed at treating and preventing COVID-19 while safeguarding vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExeVir Bio Comps
Public and private peers based on sector, stage, and business model.
ExeVir Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2023 | ||||
| Debt | Jan 9, 2023 | ||||
| Grant | Jul 13, 2021 | ||||
| Series A Extension | Mar 16, 2021 | ||||
| Series A | Jul 28, 2020 |
Key People
Founding team and executive leadership
ExeVir Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A, Series A Extension |
| Federal Holding and Investment Company | Series A Extension, Series A |
| Noshaq | Series A Extension |
| Fund+ | Series A Extension, Series A |
| Société Régionale d'Investissement de Wallonie | Series A Extension |
| European Investment Bank Group | Debt |
| V-Bio Ventures | Series A Extension, Series A |
ExeVir Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ExeVir Bio's valuation, stock price, and market status.
